Skip to main content

Table 3 Subgroup analysis for the risk of primary outcome by baseline AIP quartiles (1 quartile increment)

From: Association between the atherogenic index of plasma and major adverse cardiovascular events among non-diabetic hypertensive older adults

 

AIP Quartiles (1 Q increment)

  

Subgroup

HR, 95%CI

P value

P for interaction

Sex

  

0.336

 Male

1.67 (1.11, 2.52)

0.014

 

 Female

1.28 (0.80, 2.05)

0.305

 

Age group

  

0.816

  < 75

1.31 (0.89, 1.92)

0.174

 

  ≥ 75

1.39 (0.91, 2.11)

0.129

 

Race

  

0.398

 Black

1.34 (0.77, 2.31)

0.302

 

 No-black

1.72 (1.20, 2.47)

  

Previous CVD

  

0.932

 Yes

1.62 (1.01, 2.58)

0.044

 

 No

1.65 (1.14, 2.40)

0.008

 

Previous CKD

  

0.981

 Yes

1.65 (1.04, 2.61)

0.034

 

 No

1.64 (1.13, 2.38)

0.01

 

CVD risk

  

0.423

  < 15%

1.47 (0.88, 2.46)

0.141

 

  ≥ 15%

1.86 (1.27, 2.72)

0.001

 

Aspirin use

  

0.912

 Yes

1.66 (1.13, 2.43)

0.009

 

 No

1.61 (1.03, 2.52)

0.035

 

Statin use

  

0.350

 Yes

1.84 (1.22, 2.77)

0.003

 

 No

1.45 (0.96, 2.19)

0.074

 
  1. Model was adjusted for all covariates in Model 3 except stratifications itself